Skip to content
2000
Volume 9, Issue 9
  • ISSN: 1389-2002
  • E-ISSN: 1875-5453

Abstract

The introduction of in vitro tools to predict clearance in the early discovery process has led to new ways of working. Combined with metabolite identification, such tools have allowed design of compounds with low clearance. Encouraged by the success of such an approach and by the better knowledge of the enzyme involved in the metabolism, in vitro teams have begun to develop a plethora of assays to assess the metabolic clearance, understand the route of metabolism, and predict the human clearance. Although the diversity of assays may have allowed a more thorough approach to addressing specific issues, in the time of budget constrictions, limited access to resources and materials in vitro teams have now to decide what are the ‘must have’ and ‘nice to have’ assays to enable them to help as efficiently as possible projects at the discovery stage. Reducing the number of assays and focusing on the most relevant ones is an option to consider. Knowledge of the main enzymes involved in the drug metabolism should help to select the most relevant in vitro tools. Although the systems presented here have their merits, the author proposes that hepatocytes should be considered as the in vitro tool of choice.

Loading

Article metrics loading...

/content/journals/cdm/10.2174/138920008786485146
2008-11-01
2025-09-18
Loading full text...

Full text loading...

/content/journals/cdm/10.2174/138920008786485146
Loading

  • Article Type:
    Research Article
Keyword(s): FMO; fraction S9; GST; hepatocytes; In vitro drug metabolism; microsomes; NAT; P450; SULT; UGT
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test